Cortactin autoantibodies in myasthenia gravis

Autoimmunity Reviews

Volumn 13, Issue 10, 2014, Pages 1003-1007

  Gallardo, Eduard ^a   Martínez Hernández, Eugenia ^a   Titulaer, Maarten J ^b   Huijbers, Maartje G ^c   Martínez, Maria Angeles ^a   Ramos, Alba ^a   Querol, Luis ^a   Díaz Manera, Jordi ^a   Rojas García, Ricard ^a   Hayworth, Christopher R ^d   Verschuuren, Jan J ^c   Balice Gordon, Rita ^d   Dalmau, Josep ^e,f,g   Illa, Isabel ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF BARCELONA   (Spain)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

Acetylcholine receptor; Cortactin; Musk; Myasthenia

Indexed keywords

AUTOANTIBODY; CHOLINERGIC RECEPTOR; CORTACTIN; LIPOPROTEIN RELATED PROTEIN 4; PROTEIN DERIVATIVE; PROTEIN KINASE; UNCLASSIFIED DRUG; CTTN PROTEIN, HUMAN;

ANTIBODY DETECTION; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MALE; MYASTHENIA GRAVIS; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; REVIEW; WESTERN BLOTTING; IMMUNOLOGY; PROTEIN MICROARRAY;

AUTOANTIBODIES; CORTACTIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MYASTHENIA GRAVIS; PROTEIN ARRAY ANALYSIS; RECEPTORS, CHOLINERGIC;

EID: 84908142484     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2014.08.039     Document Type: Review

References (28)

1. Gilhus N.E. Myasthenia and the neuromuscular junction. Curr Opin Neurol 2012, 25:523-529.
2. Berrih-Aknin S., Souroujon M.C. Cutting edge in myasthenia gravis. Autoimmun Rev 2013, 12:861-862.
3. Drachman D.B., de Silva S., Ramsay D., Pestronk A. Humoral pathogenesis of myasthenia gravis. Ann N Y Acad Sci 1987, 505:90-105.
4. Engel A.G., Lindstrom J.M., Lambert E.H., Lennon V.A. Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model. Neurology 1977, 27:307-315.
5. Querol L., Illa I. Myasthenia gravis and the neuromuscular junction. Curr Opin Neurol 2013, 26:459-465.
6. Hoch W., McConville J., Helms S., Newsom-Davis J., Melms A., Vincent A. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 2001, 7:365-368.
7. McConville J., Farrugia M.E., Beeson D., Kishore U., Metcalfe R., Newsom-Davis J., et al. Detection and characterization of MuSK antibodies in seronegative myasthenia gravis. Ann Neurol 2004, 55:580-584.
8. Huijbers M.G., Zhang W., Klooster R., Niks E.H., Friese M.B., Straasheijm K.R., et al. MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4. Proc Natl Acad Sci U S A 2013, 110:20783-20788.
9. Diaz-Manera J., Martinez-Hernandez E., Querol L., Klooster R., Rojas-Garcia R., Suarez-Calvet X., et al. Long-lasting treatment effect of rituximab in MuSK myasthenia. Neurology 2012, 78:189-193.
10. Evoli A., Tonali P.A., Padua L., Monaco M.L., Scuderi F., Batocchi A.P., et al. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain 2003, 126:2304-2311.
11. Romi F., Aarli J.A., Gilhus N.E. Seronegative myasthenia gravis: disease severity and prognosis. Eur J Neurol 2005, 12:413-418.
12. Burges J., Vincent A., Molenaar P.C., Newsom-Davis J., Peers C., Wray D. Passive transfer of seronegative myasthenia gravis to mice. Muscle Nerve 1994, 17:1393-1400.
13. Mier A.K., Havard C.W. Diaphragmatic myasthenia in mother and child. Postgrad Med J 1985, 61:725-727.
14. Mossman S., Vincent A., Newsom-Davis J. Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity. Lancet 1986, 1:116-119.
15. Muppidi S., Wolfe G.I. Muscle-specific receptor tyrosine kinase antibody-positive and seronegative myasthenia gravis. Front Neurol Neurosci 2009, 26:109-119.
16. Leite M.I., Jacob S., Viegas S., Cossins J., Clover L., Morgan B.P., et al. IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis. Brain 2008, 131:1940-1952.
17. Jacob S., Viegas S., Leite M.I., Webster R., Cossins J., Kennett R., et al. Presence and pathogenic relevance of antibodies to clustered acetylcholine receptor in ocular and generalized myasthenia gravis. Arch Neurol 2012, 69:994-1001.
18. Higuchi O., Hamuro J., Motomura M., Yamanashi Y. Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis. Ann Neurol 2011, 69:418-422.
19. Zhang B., Tzartos J.S., Belimezi M., Ragheb S., Bealmear B., Lewis R.A., et al. Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis. Arch Neurol 2012, 69:445-451.
20. Zisimopoulou P., Brenner T., Trakas N., Tzartos S.J. Serological diagnostics in myasthenia gravis based on novel assays and recently identified antigens. Autoimmun Rev 2013, 12:924-930.
21. Verschuuren J.J., Huijbers M.G., Plomp J.J., Niks E.H., Molenaar P.C., Martinez-Martinez P., et al. Pathophysiology of myasthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-related protein 4. Autoimmun Rev 2013, 12:918-923.
22. Dai Z., Luo X., Xie H., Peng H.B. The actin-driven movement and formation of acetylcholine receptor clusters. J Cell Biol 2000, 150:1321-1334.
23. Madhavan R., Gong Z.L., Ma J.J., Chan A.W., Peng H.B. The function of cortactin in the clustering of acetylcholine receptors at the vertebrate neuromuscular junction. PLoS One 2009, 4:e8478.
24. Peng H.B., Xie H., Dai Z. Association of cortactin with developing neuromuscular specializations. J Neurocytol 1997, 26:637-650.
25. Aarli J.A., Stefansson K., Marton L.S., Wollmann R.L. Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin. Clin Exp Immunol 1990, 82:284-288.
26. Mygland A., Tysnes O.B., Matre R., Volpe P., Aarli J.A., Gilhus N.E. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma. Ann Neurol 1992, 32:589-591.
27. Diaz-Manera J., Rojas-Garcia R., Gallardo E., Juarez C., Martinez-Domeno A., Martinez-Ramirez S., et al. Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome. Nat Clin Pract Neurol 2007, 3:405-410.
28. Vernino S., Lennon V.A. Autoantibody profiles and neurological correlations of thymoma. Clin Cancer Res 2004, 10:7270-7275.